1 CD38 Monoclonal Antibodies Market Overview
1.1 Product Overview and Scope of CD38 Monoclonal Antibodies
1.2 Classification of CD38 Monoclonal Antibodies by Type
1.2.1 Global CD38 Monoclonal Antibodies Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global CD38 Monoclonal Antibodies Revenue Market Share by Type in 2019
1.2.3 Daratumumab
1.2.4 Isatuximab
1.3 Global CD38 Monoclonal Antibodies Market by Application
1.3.1 Overview: Global CD38 Monoclonal Antibodies Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmacy
1.3.3 Laboratory Use
1.4 Global CD38 Monoclonal Antibodies Market by Regions
1.4.1 Global CD38 Monoclonal Antibodies Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of CD38 Monoclonal Antibodies (2015-2025)
1.4.3 North America (USA, Canada and Mexico) CD38 Monoclonal Antibodies Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) CD38 Monoclonal Antibodies Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) CD38 Monoclonal Antibodies Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) CD38 Monoclonal Antibodies Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) CD38 Monoclonal Antibodies Status and Prospect (2015-2025)
2 Company Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson SWOT Analysis
2.1.4 Johnson & Johnson Product and Services
2.1.5 Johnson & Johnson CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019)
2.2 Carbosynth
2.2.1 Carbosynth Details
2.2.2 Carbosynth Major Business
2.2.3 Carbosynth SWOT Analysis
2.2.4 Carbosynth Product and Services
2.2.5 Carbosynth CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019)
2.4 Janssen Biotech
2.4.1 Janssen Biotech Details
2.4.2 Janssen Biotech Major Business
2.4.3 Janssen Biotech SWOT Analysis
2.4.4 Janssen Biotech Product and Services
2.4.5 Janssen Biotech CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019)
2.5 BOC Sciences
2.5.1 BOC Sciences Details
2.5.2 BOC Sciences Major Business
2.5.3 BOC Sciences SWOT Analysis
2.5.4 BOC Sciences Product and Services
2.5.5 BOC Sciences CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019)
2.6 Creative Biolabs
2.6.1 Creative Biolabs Details
2.6.2 Creative Biolabs Major Business
2.6.3 Creative Biolabs Product and Services
2.6.4 Creative Biolabs CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global CD38 Monoclonal Antibodies Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 CD38 Monoclonal Antibodies Players Market Share
3.2.2 Top 10 CD38 Monoclonal Antibodies Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global CD38 Monoclonal Antibodies Revenue and Market Share by Regions
4.2 North America CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
4.3 Europe CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
4.5 South America CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
5 North America CD38 Monoclonal Antibodies Revenue by Countries
5.1 North America CD38 Monoclonal Antibodies Revenue by Countries (2015-2020)
5.2 USA CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
5.3 Canada CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
5.4 Mexico CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
6 Europe CD38 Monoclonal Antibodies Revenue by Countries
6.1 Europe CD38 Monoclonal Antibodies Revenue by Countries (2015-2020)
6.2 Germany CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
6.3 UK CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
6.4 France CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
6.5 Russia CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
6.6 Italy CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
7 Asia-Pacific CD38 Monoclonal Antibodies Revenue by Countries
7.1 Asia-Pacific CD38 Monoclonal Antibodies Revenue by Countries (2015-2020)
7.2 China CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
7.3 Japan CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
7.4 Korea CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
7.5 India CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
8 South America CD38 Monoclonal Antibodies Revenue by Countries
8.1 South America CD38 Monoclonal Antibodies Revenue by Countries (2015-2020)
8.2 Brazil CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
8.3 Argentina CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue CD38 Monoclonal Antibodies by Countries
9.1 Middle East & Africa CD38 Monoclonal Antibodies Revenue by Countries (2015-2020)
9.2 Saudi Arabia CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
9.3 UAE CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
9.4 Egypt CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
9.5 South Africa CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global CD38 Monoclonal Antibodies Revenue and Market Share by Type (2015-2020)
10.2 Global CD38 Monoclonal Antibodies Market Forecast by Type (2019-2024)
10.3 Daratumumab Revenue Growth Rate (2015-2025)
10.4 Isatuximab Revenue Growth Rate (2015-2025)
11 Global CD38 Monoclonal Antibodies Market Segment by Application
11.1 Global CD38 Monoclonal Antibodies Revenue Market Share by Application (2015-2020)
11.2 CD38 Monoclonal Antibodies Market Forecast by Application (2019-2024)
11.3 Pharmacy Revenue Growth (2015-2020)
11.4 Laboratory Use Revenue Growth (2015-2020)
12 Global CD38 Monoclonal Antibodies Market Size Forecast (2021-2025)
12.1 Global CD38 Monoclonal Antibodies Market Size Forecast (2021-2025)
12.2 Global CD38 Monoclonal Antibodies Market Forecast by Regions (2021-2025)
12.3 North America CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025)
12.4 Europe CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025)
12.6 South America CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
【掲載企業】
Johnson & Johnson、Carbosynth、Sanofi、Janssen Biotech、BOC Sciences、Creative Biolabs
【免責事項】
https://www.globalresearch.jp/disclaimer